View Item 

Show simple item record

Systematic Review on the Management of Chronic Constipation in North America

dc.contributor.authorBrandt, Lawrence J.en_US
dc.contributor.authorPrather, Charlene M.en_US
dc.contributor.authorQuigley, Eamonn M. M.en_US
dc.contributor.authorSchiller, Lawrence R.en_US
dc.contributor.authorSchoenfeld, Philip S.en_US
dc.contributor.authorTalley, Nicholas J.en_US
dc.date.accessioned2010-06-01T19:30:13Z
dc.date.available2010-06-01T19:30:13Z
dc.date.issued2005-07en_US
dc.identifier.citationBrandt, Lawrence J.; Prather, Charlene M.; Quigley, Eamonn M.M.; Schiller, Lawrence R.; Schoenfeld, Philip; Talley, Nicholas J. (2005). "Systematic Review on the Management of Chronic Constipation in North America." The American Journal of Gastroenterology 100(s1): S5-S21. <http://hdl.handle.net/2027.42/72642>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72642
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16008641&dopt=citationen_US
dc.format.extent235214 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing, Inc.en_US
dc.rights2005 by the American College of Gastroenterologyen_US
dc.titleSystematic Review on the Management of Chronic Constipation in North Americaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, University of Michigan School of Medicine, and Center for Excellence in Health Services Research, Veterans Affairs Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationotherDivision of Gastroenterology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NYen_US
dc.contributor.affiliationotherDivision of Gastroenterology, Saint Louis University School of Medicine, St. Louis, MOen_US
dc.contributor.affiliationotherDepartment of Medicine and Alimentary Pharmabiotic Center, National University of Ireland, Cork, Irelanden_US
dc.contributor.affiliationotherDivision of Gastroenterology, Baylor University Medical Center, Dallas, TXen_US
dc.contributor.affiliationotherDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MNen_US
dc.identifier.pmid16008641en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72642/1/j.1572-0241.2005.50613_2.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2005.50613_2.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceHayward R, Wilson M, Tunis S, et al. User's guides to the medical literature: VIII. How to use clinical practice guideline recommendations. A. Are the recommendations valid? JAMA 1995; 274: 570 – 74.en_US
dc.identifier.citedreferenceWilson M, Hayward R, Tunis S, et al. User's Guide to the medical literature: VIII. How to use clinical practice guidelines. B. What are the Recommendations and will they help you in caring for your patients. JAMA 1995: 274; 1630 – 32.en_US
dc.identifier.citedreferenceGuyatt G, Sackett D, Sinclair J, et al. User's guide to the medical literature. IX. A method for grading health care recommendations. JAMA 1995; 274: 1800 – 4.en_US
dc.identifier.citedreferenceBrandt L, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S7 – S27.en_US
dc.identifier.citedreferenceEgger M, Smith GD. Principles of and procedures for systematic reviews. In: Egger M, Smith GD, Attman DG, eds. Systematic reviews in health care, 2nd Ed. London: BMJ Publishing Group, 2001: 23 – 43.en_US
dc.identifier.citedreferenceOxman A, Guyatt G, Cook D, et al. Summarizing the Evidence. In: Guyatt G, Rennie D, eds. User's guide to the medical literature: A manual for evidence-based clinical practice, 1st ed. Chicago: AMA Press, 2001: 155 – 75.en_US
dc.identifier.citedreferenceCook D, Guyatt G, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of anti-thrombotic agents. Chest 1992; 102 ( Suppl 4 ): 3055 – 115.en_US
dc.identifier.citedreferenceVan Zanten SJO, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999; 45 ( Suppl II ): II69 – II77.en_US
dc.identifier.citedreferenceJadad A, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized controlled trials: Is blinding necessary? Controlled Clin Trials 1996; 17: 1 – 12.en_US
dc.identifier.citedreferenceSchoenfeld P, Cook D, Hamilton F, et al. An evidence based approach to gastroenterology therapy. Gastroenterology 1998; 114: 1318 – 25.en_US
dc.identifier.citedreferenceSchulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408 – 12.en_US
dc.identifier.citedreferenceChalmers TC, Celano P, Sacks HS, et al. Bias in treatment assignment in controlled clinical trials. N Engl J Med 1983; 309: 1358 – 61.en_US
dc.identifier.citedreferenceDrossman DA, Funch-Jensen P, Janssens J et al. Identification of subgroups of functional bowel disorders. Gastroenterol Int 1990; 3: 159 – 72.en_US
dc.identifier.citedreferenceThompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 ( suppl 2 ): II43 – 47.en_US
dc.identifier.citedreferenceThompson WG, Heutan KW, Smyth GT, et al. Irritable bowel syndrome: The view from general practice. Eur J Gastroenterol Hepatol 1997; 9: 689 – 92.en_US
dc.identifier.citedreferenceAshraf W, Park F, Lof J, et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996; 91: 26 – 32.en_US
dc.identifier.citedreferenceFriel JP, ed. 22nd ed. Philadelphia: W.B. Saunders, 1997.en_US
dc.identifier.citedreferenceIrvine EJ, Ferrazzi S, Pare P, et al. Health-related quality of life in functional GI disorders: Focus on constipation and resource utilization. Am J Gastroenterol 2002; 97: 1986 – 93.en_US
dc.identifier.citedreferenceHiggins PDR, Johnson JF. Epidemiology of chronic constipation in North America: A systemic review. Am J Gastroenterol 2004; 99: 750 – 9.en_US
dc.identifier.citedreferencePare P, Ferrazi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: Definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96: 3130 – 7.en_US
dc.identifier.citedreferenceHammond E. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Pub Health Nations Health 1964; 54: 11 – 23.en_US
dc.identifier.citedreferenceSandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Pub Health 1990; 80: 185 – 9.en_US
dc.identifier.citedreferenceEverhart JE, Go VL, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989; 34: 1153 – 62.en_US
dc.identifier.citedreferenceJohanson JF. Constipation. In: Everhart JE, ed. Digestive diseases in the United States: Epidemiology and impact. Vol. 94–1447. Washington, DC: U.S. Department of Health and Human Resources, Public Health Service, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease, 1994: 5667 – 94.en_US
dc.identifier.citedreferenceHarari D, Gurwitz JH, Avorn J, et al. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med 1996; 156: 315 – 20.en_US
dc.identifier.citedreferenceTalley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonic symptoms and the irritable syndrome. Gastroenterol 1991; 101: 927 – 34.en_US
dc.identifier.citedreferenceTalley NJ, Weaver AL, Zinsmeister AR, et al. Functional constipation and outlet delay: A population-based study. Gastroenterol 1993; 105: 781 – 90.en_US
dc.identifier.citedreferenceDrossman DA, Li Z, Andruzzi E, et al. U.S. house-holder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569 – 80.en_US
dc.identifier.citedreferenceStewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: Relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94: 3530 – 40.en_US
dc.identifier.citedreferenceSaito Y, Schoenfeld P, Locke GR. Epidemiology of irritable bowel syndrome in North America—A systematic review. Am J Gastroenterol 2002; 97: 1910 – 5.en_US
dc.identifier.citedreferenceTalley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003; 98: 2454 – 9.en_US
dc.identifier.citedreferenceLocke GR, III, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a USA community. Neurogastroenterol Motil 2004; 16: 1 – 6.en_US
dc.identifier.citedreferenceTalley NJ, Weaver AL, Zinsmeister AR, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165 – 77.en_US
dc.identifier.citedreferenceLocke GR, III, Pemberton JH, Phillips SF. AGA technical review on constipation. Gastroenterol 2000; 119: 1161 – 78.en_US
dc.identifier.citedreferenceCash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review. Am J Gastroenterol 2002; 97: 2812 – 9.en_US
dc.identifier.citedreferenceLijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061 – 6.en_US
dc.identifier.citedreferencePepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: Survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc 2002; 56: 325 – 32.en_US
dc.identifier.citedreferenceAmerican Society for Gastrointestinal Endoscopy Practice Parameters Committee. Guideline on the Use of Endoscopy in the Management of Constipation. ASGE Press, 2005. in press.en_US
dc.identifier.citedreferencePatriquin H, Martelli H, Devroede G. Barium enema in chronic constipation: Is it meaningful? Gastroenterol 1978; 75: 619 – 22.en_US
dc.identifier.citedreferenceGerson DE, Lewicki AM, McNeil BJ, et al. The barium enema; evidence for proper utilization. Radiology 1979; 130: 297 – 301.en_US
dc.identifier.citedreferenceWald A. Diagnosis of constipation in primary and secondary care. Rev Gastroenterol Disord 2004; 4 ( suppl. 2 ): S28 – 33.en_US
dc.identifier.citedreferenceLembo A, Camilleri M. Chronic Constipation. N Engl J Med 2003; 349: 1360 – 8.en_US
dc.identifier.citedreferenceXing JH, Soffer E. Adverse effects of laxatives. Dis Colon Rectum 2001; 44: 1201 – 9.en_US
dc.identifier.citedreferenceCheskin LJ, Kamal N, Crowell MD, et al. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc 1995; 43: 666 – 9.en_US
dc.identifier.citedreferenceFenn GC, Wilkinson PD, Lee CE, et al. A general practice study of the efficacy of Regulan in functional constipation. Br J Clin Pract 1986; 40: 192 – 7.en_US
dc.identifier.citedreferenceAshraf W, Park F, Lof J, et al. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther 1995; 9: 639 – 47.en_US
dc.identifier.citedreferenceDettmar PW, Sykes J. A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation. Curr Med Res Opin 1998; 14: 227 – 33.en_US
dc.identifier.citedreferenceRouse M, Chapman N, Mahapatra M, et al. An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults. Br J Clin Pract 1991; 45: 28 – 30.en_US
dc.identifier.citedreferenceMamtani R, Cimino JA, Kugel R, et al. A calcium salt of an insoluble synthetic bulking laxative in elderly bedridden nursing home residents. J Am Coll Nutr 1989; 8: 554 – 6.en_US
dc.identifier.citedreferenceHamilton JW, Wagner J, Burdick BB, et al. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci 1988; 33: 993 – 8.en_US
dc.identifier.citedreferenceBadiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995; 40: 349 – 56.en_US
dc.identifier.citedreferenceAnderson AS, Whichelow MJ. Constipation during pregnancy: Dietary fibre intake and the effect of fibre supplementation. Hum Nutr Appl Nutr 1985; 39: 202 – 7.en_US
dc.identifier.citedreferenceGraham DY, Moser SE, Estes MK. The effect of bran on bowel function in constipation. Am J Gastroenterol 1982; 77: 599 – 603.en_US
dc.identifier.citedreferenceTramonte SM, Brand MB, Mulrow CD, et al. The treatment of chronic constipation in adults: A systematic review. J Gen Intern Med 1997; 12: 15 – 24.en_US
dc.identifier.citedreferenceJones MP, Talley NJ, Nuyts G, et al. Lack of objective efficacy of laxatives in chronic constipation. Dig Dis Sci 2002; 47: 2222 – 30.en_US
dc.identifier.citedreferenceCastle SC, Cantrell M, Israel DS, et al. Constipation prevention: Empiric use of stool softeners questioned. Geriatrics 1991; 46: 84 – 6.en_US
dc.identifier.citedreferenceHyland CM, Foran JD. Dioctyl sodium sulphosuccinate as a laxative in the elderly. Practitioner 1968; 200: 698 – 9.en_US
dc.identifier.citedreferenceFain AM, Susat R, Herring M, et al. Treatment of constipation in geriatric and chronically ill patients: A comparison. S Med Assoc J 1978; 71: 677 – 80.en_US
dc.identifier.citedreferenceMcRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 1998; 12: 491 – 7.en_US
dc.identifier.citedreferenceXing JH, Soffer E. Adverse effects of laxatives. Dis Colon Rectum 2001; 44: 1201 – 9.en_US
dc.identifier.citedreferenceBass P, Dennis S. The laxative effects of lactulose in normal and constipated subjects. J Clin Gastroenterol 1981; 3: 23 – 8.en_US
dc.identifier.citedreferenceSanders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978; 26: 236 – 9.en_US
dc.identifier.citedreferenceWesselius-De Casparis A, Braadbaart S, Bergh-Bohlken GE, et al. Treatment of chronic constipation with lactulose syrup: Results of a double-blind study. Gut 1968; 9: 84 – 6.en_US
dc.identifier.citedreferenceAndorsky RI, Goldner F. Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 1990; 85: 261 – 5.en_US
dc.identifier.citedreferenceCleveland MV, Flavin DP, Ruben RA, et al. New polyethylene glycol laxative for treatment of constipation in adults: A randomized, double-blind, placebo-controlled study. S Med Assoc J 2001; 94: 478 – 81.en_US
dc.identifier.citedreferenceCorazziari E, Badiali D, Habib FI, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 1996; 41: 1636 – 42.en_US
dc.identifier.citedreferenceCorazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000; 46: 522 – 6.en_US
dc.identifier.citedreferenceDiPalma JA, DeRidder PH, Orlando RC, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. [comment]. Am J Gastroenterol 2000; 95: 446 – 50.en_US
dc.identifier.citedreferenceFreedman MD, Schwartz HJ, Roby R, et al. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: A double-blinded placebo-controlled trial. J Clin Pharmacol 1997; 37: 904 – 7.en_US
dc.identifier.citedreferenceAttar A, Lemann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999; 44: 226 – 30.en_US
dc.identifier.citedreferenceKinnunen O, Salokannel J. Constipation in elderly long-stay patients: Its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res 1987; 19: 321 – 3.en_US
dc.identifier.citedreferenceXing JH, Soffer E. Adverse Effects of Laxatives. Dis Colon Rectum 2001; 44: 1201 – 9.en_US
dc.identifier.citedreferenceMacLennan WJ, Pooler A. A comparison of sodium picosulphate (“Laxoberal”) with standardised senna (“Senokot”) in geriatric patients. Curr Med Res Opin 1974; 2: 641 – 7.en_US
dc.identifier.citedreferenceMcCallum G, Ballinger BR, Presly AS. A trial of bran and bran biscuits for constipation in mentally handicapped and psychogeriatric patients. J Hum Nutr 1978; 32: 369 – 72.en_US
dc.identifier.citedreferenceRider JA. Treatment of acute and chronic constipation with bisoxatin acetate and bisacodyl. Double-blind crossover study. Curr Ther Res Clin Exp 1971; 13: 386 – 92.en_US
dc.identifier.citedreferenceConnolly P, Hughes IW, Ryan G. Comparison of “Duphalac” and “irritant” laxatives during and after treatment of chronic constipation: A preliminary study. Curr Med Res Opin 1974; 2: 620 – 5.en_US
dc.identifier.citedreferenceCamilleri M. Review article: Tegaserod. Aliment Pharmacol Ther 2001; 15: 777 – 89.en_US
dc.identifier.citedreferencePrather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates oro-cecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterol 2000; 118: 463 – 8.en_US
dc.identifier.citedreferenceGegen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001; 15: 1745 – 51.en_US
dc.identifier.citedreferenceJohanson J, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004; 2: 796 – 805.en_US
dc.identifier.citedreferenceKamm M, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: A randomized, double blind, placebo-controlled multinational study. Am J Gastroenterol 2005; 100: 372 – 82.en_US
dc.identifier.citedreference6.  Briefing document on Zelnorm (Tegaserod) for the FDA Joint GI Drugs Advisory Committee and Drug Safety and Risk Management Sub-Committee. July 14, 2004en_US
dc.identifier.citedreferenceOdes HS, Madar Z. A double-blind trial of a celandin, aloe vera, and psyllium laxative preparation in adult patients with constipation. Digestion 1991; 49: 65 – 71.en_US
dc.identifier.citedreferenceTolia V, Lin CH, Elitsur Y. A prospective randomized study with mineral oil and oral lavage solution for treatment of faecal impaction in children. Aliment Pharmacol Ther 1993; 5: 523 – 29.en_US
dc.identifier.citedreferenceSondheimer JM, Gervaise EP. Lubricant versus laxative in the treatment of chronic functional constipation of children: A comparative study. J Pediatr Gastroenterol Nurs 1982; 1: 223 – 6.en_US
dc.identifier.citedreferenceHeyman S, Jones R, Scarlett Y, et al. Biofeedback treatment of constipation: A critical review. Dis Colon Rectum 2003; 46: 1208 – 17.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2005.50613_2.x.pdf
Size:
229.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.